logo

Diseases and Drugs

Share

fda july23 27jul21 As July comes to a close, it's time to look back on some of the month's most important news and look forward to what August has in store. In a recent town hall meeting, the US President Joe Biden stated that he expected the FDA to fully approve the COVID-19 vaccines as soon as late August or early September.

fda jun23 As June draws to a close, it's time to take a look back on some of the month's top news stories related to FDA approval and look ahead to what July has in store.

fda may24 So far this month, only 2 *novel drugs have secured regulatory approval in the U.S. - Johnson & Johnson's Rybrevant and Apellis Pharmaceuticals' Empaveli - compared to 6 during the same period last year. Now, let's take a look at the biotech stocks facing FDA decision in June 2021.

fdadecision april28 27mar21 Four novel drugs were approved by the FDA in March taking the tally of new drug approvals in the first quarter of this year to 14. Let's take a look at what's in store for April 2021.

fdaaprovedim sep19 The Food and Drug Administration approved four new drugs last month. In the year 2020, 104 new drugs were approved by the FDA. Now, let us take a look at the new drugs approved by the regulator in January 2021.

fda2021 dec29 As 2020 draws to a close, it's time to take a look back at some of the regulatory news that made headlines in December and look ahead at what's in store for January 2021. As for the novel drug approvals, 53 drugs secured FDA nod in 2020 compared to 48 in 2019. Let's take a look at the biotech companies whose drugs are at the FDA altar awaiting a decision in January 2021.

oxlumo nov37 As November comes to a close, it's time to take a look back at some of the top news stories of the month related to FDA approvals and look ahead at what's in store for December. A couple of firsts happened on the regulatory front in the month. Let's take a look at the biotech stocks that await a ruling from the FDA in December.

syringesvials nov25 Vaccination is an effective way to halt a pandemic. In the ongoing COVID-19 pandemic, the number of confirmed cases across the globe has crossed 60 million, with over 1.42 million fatalities, as of this writing. The U.S., which has reported 12.77 million cases and over 262,000 deaths, remains the worst-hit country.

vaccine nov16 An effective coronavirus vaccine is one good way to put an end to the pandemic. According to the World Health Organization, 48 vaccines targeting the SARS-CoV-2 virus are in clinical evaluation and 168 are in preclinical stage.

fdaapproved nov16 Four new drugs were approved by the FDA in the month of October. This compares with 11 drugs approved by the regulator last year.

fda oct23 On October 22, the FDA approved Gilead's (GILD) Veklury (remdesivir), the first drug for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization. Let's take a look at the companies that await a ruling from the FDA in November.

drug sept25 As of this writing, the FDA has approved 40 novel drugs so far this year compared to just 27 during the same period (Jan-Sep) last year. Now, let's take a look at the biotech stocks facing FDA decision in October.

russia aug25 So far this year, 36 novel drugs have passed muster with the FDA compared to 26 during the same period (Jan- Aug) in 2019. Let's take a look at the companies that await a ruling from the FDA in September.

Follow RTT